Skip to content

Anxiety: all studies

Page 293 of 772: studies 2,921 to 2,930 of 7,715, newest first. Back to the anxiety overview

Research

Long-Term Neuropsychiatric Consequences of "Ecstasy" (MDMA): A Review

Harvard Review of Psychiatry 2002 Alonso Montoya, Renée Sorrentino, Scott E Lukas et al. 102 citations

The recreational drug "ecstasy" (3,4-methylenedioxymethamphetamine, or MDMA) is widely used by young people throughout the world. Experimental studies indicate that MDMA damages serotonergic neurons in animals and possibly in humans. Repeated use may induce long-term neurotoxic effects, with cognitive and behavioral implications. We reviewed both the preclinical and the clinical literature to...

Cannabis‐induced Koro in Americans

Addiction November 1, 2001 Mitch Earleywine 57 citations

AIMS: Koro, an acute panic reaction related to the perception of penile retraction, was once considered limited to specific cultures. The disorder has appeared as part of a panic response to cannabis, but only in citizens of India. This study looked for cannabis-induced Koro in Americans. DESIGN: Given the relative rarity of cannabis-induced Koro, this work focused on individual case studies....

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

Journal of Psychopharmacology May 1, 2001 Nicholas Macinnes, Sheila L. Handley, G. F. A. Harding 120 citations

Previous work has indicated recreational use of methylenedioxymethamphetamine (MDMA or ecstasy) is associated with elevated scores on self-report measures of depression. We sought to examine the long-term effects of consumption on depression in a group of individuals who had consumed large quantities of the drug in the past, but were now leading relatively drug free lives. Respondents to this...

Gender differences in the subjective effects of MDMA

Psychopharmacology March 5, 2001 Matthias E. Liechti, Alex Gamma, Franz X. Vollenweider 357 citations

Rationale3.4-Methylenedioxymethamphetamine (MDMA) mainly releases serotonin (5-HT) and is contained in the recreational drug Ecstasy. 5-HT is known to play an important role in mood and anxiety disorders, for which there is a female preponderance. To date, there are no systematic data on gender differences in the subjective effects of MDMA.ObjectivesThe present work analyzed the pooled data...

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

Psychopharmacology February 22, 2001 Jordi Riba, Antoni Rodrı́guez-fornells, Gloria Urbano et al. 302 citations

RationaleAyahuasca is a South American psychoactive beverage that contains the naturally occurring psychedelic agent N,N-dimethyltryptamine (DMT). This "tea" has been used for centuries in religious and medicinal contexts in the rain forest areas of South America and is presently gaining the attention of psychedelic users in North America and Europe.ObjectivesIn the present study, the...

No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study

Journal of Clinical Psychopharmacology February 1, 2001 Alex Gamma, Alfred Buck, Thomas Berthold et al. 84 citations

The long-term use of the serotonin-releaser and uptake-inhibitor 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been associated with memory impairments and increased liability to depressive mood and anxiety attacks. It is unclear, however, whether these psychologic deviations are reflected in alterations of the underlying neurophysiologic substrate. The authors compared mood and...

A Randomized, Wait-List Controlled Clinical Trial: The Effect of a Mindfulness Meditation-Based Stress Reduction Program on Mood and Symptoms of Stress in Cancer Outpatients

Psychosomatic Medicine September 1, 2000 Michael Speca, Linda E. Carlson, Eileen Goodey et al. 1,091 citations

OBJECTIVE: The objective of this study was to assess the effects of participation in a mindfulness meditation-based stress reduction program on mood disturbance and symptoms of stress in cancer outpatients. METHODS: A randomized, wait-list controlled design was used. A convenience sample of eligible cancer patients enrolled after giving informed consent and were randomly assigned to either an...

Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.

Journal of Consulting and Clinical Psychology 2000 John D. Teasdale, Zindel V. Segal, James Williams et al. 2,613 citations

This study evaluated mindfulness-based cognitive therapy (MBCT), a group intervention designed to train recovered recurrently depressed patients to disengage from dysphoria-activated depressogenic thinking that may mediate relapse/recurrence. Recovered recurrently depressed patients (n = 145) were randomized to continue with treatment as usual or, in addition, to receive MBCT....

DOI: 10.1037//0022-006x.68.4.615 (opens in new tab) Anxiety Mindfulness-based cognitive therapy Relapse prevention Dysphoria +5

Mood state and brain electric activity in Ecstasy users

Neuroreport 2000 Alex Gamma, Edi Frei, Dietrich Lehmann et al. 81 citations

Resting EEG during open and closed eyes and subsequent mood ratings were obtained from 15 Ecstasy users and 14 Ecstasy-naive controls. Absolute spectral power on the scalp, and the three-dimensional, intracerebral distribution of neuroelectric activity using low resolution brain electromagnetic tomography (LORETA) were computed. LORETA revealed global increases of theta, alpha 1 and beta 2/3...

Altered Beliefs, Attitudes, and Behaviors Following Near-Death Experiences

Journal of Humanistic Psychology July 1, 1998 Gary Groth‐marnat, Roger Summers 66 citations

This study investigated the extent and types of altered beliefs, attitudes, and values of 53 subjects who reported having had a neardeath experience (NDE). A control group was composed of 27 individuals who reported having had similar life-threatening incidents but without a corresponding NDE. In addition, 45 significant others in the lives of the participants in these groups rated the extent...

DOI: 10.1177/00221678980383005 (opens in new tab) Afterlife Paranormal Phenomenon Death anxiety +4